6-EAPB

6-EAPB, also known as 1-(benzofuran-6-yl)-N-ethylpropan-2-amine, is a potentially psychedelic and potentially entactogenic drug of the benzofuran class;^[1] it is structurally related to 6-APB and MDMA.

6-EAPB

Legal status
Legal status	AU: Analogue of MDMA CA: Schedule I DE: NpSG (Industrial and scientific use only) UK: Class B US: Analogue to a Schedule I/II drug (MDMA)
Identifiers
IUPAC name 1-(benzofuran-6-yl)-N-ethylpropan-2-amine
CAS Number	1632539-47-9 Y
ChemSpider	57427400
UNII	LWB2M746C9
Chemical and physical data
Formula	C13H17NO
Molar mass	203.285 g·mol−1
3D model (JSmol)	Interactive image
SMILES CCNC(CC1=CC2=C(C=CO2)C=C1)C
InChI InChI=1S/C13H17NO.ClH/c1-3-14-10(2)8-11-4-5-12-6-7-15-13(12)9-11;/h4-7,9-10,14H,3,8H2,1-2H3;1H Key:MUFUSNCKTVRMLR-UHFFFAOYSA-N

Pharmacology

Pharmacodynamics

6-EAPB is a potent monoamine reuptake inhibitor.^[2] It shows very low potency as a serotonin 5-HT_2A receptor agonist.^[2]

Society and culture

Legal status

As an N-ethyl derivative of 6-APB, 6-EAPB fell outside the scope of the Temporary Class Drug ban issued by the Home Office on June 10, 2013.^[3] The ACMD has advised that 6-EAPB (and other benzofurans) are moved to Class B,^[4] this came into action on 10 June 2014.^[5]

See also

• Substituted benzofuran